How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Roche Diagnostics in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
185 clearance records and 0 recall records in the covered releases, across 1 source company names and 84 product codes. Dated history runs from Jan 31, 2005 to Oct 2, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 2 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 1 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 2 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 5 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 1 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 1 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 3 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Elecsys EBV EBNA IgGK260221 · LSE | Roche Diagnostics | 510(k) | Oct 2, 2026FDA decision date |
| Elecsys EBV VCA IgGK260232 · LSE | Roche Diagnostics | 510(k) | Oct 2, 2026FDA decision date |
| Elecsys EBV IgMK260233 · LJN | Roche Diagnostics | 510(k) | Oct 2, 2026FDA decision date |
| Elecsys Phospho-Tau (217P) PlasmaK261686 · SET | Roche Diagnostics | 510(k) | Aug 19, 2026FDA decision date |
| cobas pulse blood glucose monitoring systemK252323 · PZI | Roche Diagnostics | 510(k) | Jun 12, 2026FDA decision date |
| Elecsys Anti-SARS-CoV-2 SK252280 · QVP | Roche Diagnostics | 510(k) | Apr 13, 2026FDA decision date |
| Elecsys Anti-HBc IIK260046 · SEI | Roche Diagnostics | 510(k) | Apr 7, 2026FDA decision date |
| Elecsys Anti-HAV IgMK260048 · LOL | Roche Diagnostics | 510(k) | Apr 7, 2026FDA decision date |
| Elecsys Anti-HBc IgMK260049 · SEI | Roche Diagnostics | 510(k) | Apr 7, 2026FDA decision date |
| Tina-quant Cardiac high sensitivity CRP IIIK260026 · NQD | Roche Diagnostics | 510(k) | Apr 2, 2026FDA decision date |
| Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsK253490 · CFR | Roche Diagnostics | 510(k) | Feb 12, 2026FDA decision date |
| ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutionsK253491 · CEM | Roche Diagnostics | 510(k) | Feb 12, 2026FDA decision date |
| Elecsys Anti-SARS-CoV-2K253839 · QVP | Roche Diagnostics | 510(k) | Dec 17, 2025FDA decision date |
| CoaguChek XS Plus SystemK253188 · GJS | Roche Diagnostics | 510(k) | Oct 24, 2025FDA decision date |
| Elecsys Phospho-Tau (181P) PlasmaK252163 · SET | Roche Diagnostics | 510(k) | Oct 8, 2025FDA decision date |
| Elecsys Cortisol IIIK242505 · JFT | Roche Diagnostics | 510(k) | Jul 17, 2025FDA decision date |
| Elecsys Anti-SARS-CoV-2K250768 · QVP | Roche Diagnostics | 510(k) | Jun 10, 2025FDA decision date |
| Elecsys sFlt-1 and Elecsys PlGFK241453 · QWH | Roche Diagnostics | 510(k) | Feb 7, 2025FDA decision date |
| Elecsys Folate IIIK233060 · CGN | Roche Diagnostics | 510(k) | Jun 17, 2024FDA decision date |
| cobas pulse blood glucose monitoring systemK220272 · PZI | Roche Diagnostics | 510(k) | Apr 26, 2024FDA decision date |
| Elecsys PTH , Elecsys PTH STATK231927 · CEW | Roche Diagnostics | 510(k) | Mar 22, 2024FDA decision date |
| Elecsys Tg IIK221890 · MSW | Roche Diagnostics | 510(k) | Sep 30, 2023FDA decision date |
| Elecsys Anti-TgK222610 · JZO | Roche Diagnostics | 510(k) | Sep 15, 2023FDA decision date |
| Elecsys proBNP II, Elecsys proBNP II STATK223637 · NBC | Roche Diagnostics | 510(k) | Jul 21, 2023FDA decision date |
| Elecsys ß-Amyloid (1-42) CSF II, Elecsys Total-Tau CSFK231348 · QSE | Roche Diagnostics | 510(k) | Jun 5, 2023FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.